TYSON PARKER: Open Payments
NPI 1295921484 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,794 in 104 payments from 33 companies in 2025. Trend: 2023 $1,747 · 2024 $1,995 · 2025 $1,794
Food & beverage: $1,794
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $380 |
| Vanda Pharmaceuticals Inc. | 8 | $240 |
| Lilly USA, LLC | 6 | $100 |
| GlaxoSmithKline, LLC. | 6 | $89 |
| Antares Pharma, Inc. | 4 | $86 |
| Astellas Pharma US Inc | 3 | $85 |
| Boston Scientific Corporation | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $79 |
| Phathom Pharmaceuticals, Inc. | 6 | $56 |
| Dexcom, Inc. | 2 | $50 |
Products named: FANAPT, VRAYLAR, QULIPTA, MOUNJARO, TRELEGY ELLIPTA, XYOSTED, Veozah, Kerendia.
Industry payments across ID — which companies pay providers there.
